Healthcare Services Group Azioni (NASDAQ: HCSG)

Ultime notizie per Healthcare Services Group (NASDAQ:HCSG) Azioni

Healthcare Services Group

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

Healthcare Services Group, Inc. - Common Stock

Healthcare Services Group Inc

HEALTHCARE SERVICES GROUP ORD

<a href="https://x.com/H4ckManac/status/1849812559810949625" title="https://x.com/H4ckManac/status/1849812559810949625">https://x.com/H4ckManac/status/1849812559810949625</a>

News

HCSG

HackManac Posts On X "Underground Team hacking group claims to have breached Healthcare Services Group. Allegedly, 1.1 TB of data were exfiltrated, including confidential documents, agreements, contracts, financial and legal documents, vendor and supplier information, stockholder documentation, tax and recruitment documents, service proposals, invoices, and extensive employee information (including passports, IDs, SSNs, and various tax and payroll forms)."

Benchmark analyst Bill Sutherland reiterates Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Buy and maintains $17 price target.

Price Target

Reiteration

Analyst Ratings

Benchmark Reiterates Buy on Healthcare Services Group, Maintains $17 Price Target

Baird analyst Andrew Wittmann maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Neutral and lowers the price target from $14 to $12.

Baird Maintains Neutral on Healthcare Services Group, Lowers Price Target to $12

Reaffirms Q4 revenue estimate of $430.0 to $440.0 million and FY 2024 cash flow forecast of $40.0 to $55.0 million.

Earnings

Guidance

Health Care

General

Healthcare Services Group Reaffirms Its Q4 2024 Revenue Guidance Of $430M-$440M Versus Consensus Of $435.09M

Earnings Misses

Healthcare Services Group Q3 2024 GAAP EPS $0.19 Misses $0.20 Estimate, Sales $428.149M Miss $429.663M Estimate

The Company will continue to monitor the situation and take appropriate actions consistent with its response protocols. As of the date of this filing, the incident has not caused, and is not expected to cause, disruption of the Company&rsquo;s business operations.
And although the full nature and scope of the incident is not yet known, the Company does not believe it will have a material effect on its financial condition or results of operations.

Healthcare Services Group Identified Cybersecurity Incident Involving Unauthorized Activity Within Some Of Its Systems; Expects No Disruption, Material Effect On Operations - Filing

Healthcare Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) today announced the appointment of Vikas Singh as EVP &amp; Chief Financial Officer, effective September 3, 2024. He will oversee HCSG's accounting and finance operations, and play a key role in corporate development, investor relations, and the success of its long-term growth strategy.
Mr. Singh brings over two decades of diverse experience in finance, strategy and operations to the Company. Most recently, he served as Managing Director of Leveraged Finance &amp; Capital Markets at Bank of America Securities. Prior to that he worked in the Financial Sponsors Group at Credit Suisse and in the Asia-Pacific Credit Card Group at Citibank. Mr. Singh began his career with GSK's Consumer Healthcare Division and held roles in Sales Management and as National Brand Manager within the marketing organization.

Management

HCSG Announces Appointment Of Vikas Singh As Chief Financial Officer, Effective September 3, 2024

RBC Capital analyst Sean Dodge maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Outperform and lowers the price target from $15 to $14.

RBC Capital Maintains Outperform on Healthcare Services Group, Lowers Price Target to $14

Baird analyst Andrew Wittmann maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Neutral and raises the price target from $13 to $14.

Baird Maintains Neutral on Healthcare Services Group, Raises Price Target to $14

Healthcare Services Group Expects Q3 And Q4 Revenue Of $425M-$435M And $430M-$440M, Compared To Consensus Of $431.14M And $437.04M, Respectively

Healthcare Services Group Q2 2024 Adj. EPS $0.20, Inline, Sales $426.288M Beat $424.901M Estimate

Healthcare Services Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) today issued the following statement in response to LaVie Care Centers' announcement that it had filed for Chapter 11 bankruptcy protection in the Northern District of Georgia. As a result of LaVie's filing, the Company estimates a Q2 non-cash charge of approximately $0.20 per share. The Company expects to continue providing services to LaVie and expects no impact on future revenue or earnings. Additionally, the Company anticipates no disruption in postpetition payments and reiterates its previously shared Q2 and 2024 adjusted cash flow expectations of $5.0 million to $15.0 million and $40.0 million to $55.0 million, respectively.

HCSG Provides Update On Client Restructuring; Estimates A Q2 Non-cash Charge Of ~$0.20 Per Share, Anticipates No Disruption In Postpetition Payments And Reiterates Its Previously Shared Q2 And 2024 Adjusted Cash Flow Expectations Of $5M-$15M And $40M-$55M

Healthcare Services Reiterates 2024 Forecast For Adjusted Cash Flow Range Of $40M-$55M; Expects Q2 Revenue In The Range Of $420M-$430M Vs. $430.417M Consensus

Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.19 by 15.79 percent. This is a 10 percent increase over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $423.433 which missed the analyst consensus estimate of $424.949 million by 100.00 percent. This is a 100.00 percent decrease over sales of $417.230 million the same period last year.

Earnings Beats

Healthcare Services Group Q1 2024 Adj EPS $0.22 Beats $0.19 Estimate, Sales $423.433 Miss $424.949M Estimate

Benchmark analyst Bill Sutherland maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Buy and raises the price target from $16 to $17.

Benchmark Maintains Buy on Healthcare Services Group, Raises Price Target to $17

Across the recent three months, 5 analysts have shared their insights on Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Healthcare Services Group, presenting an average target of $13.6, a high estimate of $16.00, and a low estimate of $11.00. This upward trend is apparent, with the current average reflecting a 16.54% increase from the previous average price target of $11.67.
<img src="https://www.benzinga.com/files/images/story/2024/1708020033_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of Healthcare Services Group by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>A.J. Rice</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Sean Dodge</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Bill Sutherland</td>
<td>Benchmark</td>
<td>Maintains</td>
<td>Buy</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>A.J. Rice</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$11.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Healthcare Services Group. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Healthcare Services Group compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Healthcare Services Group's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into Healthcare Services Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HCSG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Healthcare Services Group analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Healthcare Services Group Better</h2>
Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.
<h3>Key Indicators: Healthcare Services Group's Financial Health</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Healthcare Services Group's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2023, the company experienced a revenue decline of approximately -0.75%. This indicates a decrease in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.34%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of -1.23%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Healthcare Services Group's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.73%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Healthcare Services Group's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.13.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Evaluating Healthcare Services Group: Insights From 5 Financial Analysts

RBC Capital analyst Sean Dodge maintains Healthcare Services Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCSG#NASDAQ">HCSG</a>) with a Outperform and raises the price target from $14 to $15.

RBC Capital Maintains Outperform on Healthcare Services Group, Raises Price Target to $15

U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining around 100 points on Wednesday.
The Dow traded up 0.11% to 38,313.27 while the NASDAQ rose 0.70% to 15,765.18. The S&amp;P 500 also rose, gaining, 0.49% to 4,977.43.
Check This Out: <a href="https://www.benzinga.com/news/24/02/37091624/snap-american-express-and-2-other-stocks-insiders-are-selling"> Snap, American Express And 2 Other Stocks Insiders Are Selling</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Industrials shares rose by 1.1% on Wednesday.
In trading on Wednesday, consumer staples shares fell by 0.6%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Crude oil inventories in the U.S. surged by 12.018 million barrels in the week ending Feb. 9, compared to market estimates of a 2.56 million rise.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
enGene Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) shares shot up 83% to $13.95. The company&rsquo;s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day&rsquo;s closing price.
Shares of Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) got a boost, surging 33% to $16.10 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 billion, up 17% year-over-year. The company&rsquo;s CFO, Erin Brewer, said the adjusted EBITDA margin is projected to expand 50 basis points in 2024.
Healthcare Services Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) shares were also up, gaining 26% to $11.91 following upbeat earnings.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
Azitra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aztr#NYSE">AZTR</a>) shares dropped 71% to $0.2540. Azitra priced its $5 million public offering of 16.667 million common shares at $0.30 per share.
Shares of QuidelOrtho Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qdel#NASDAQ">QDEL</a>) were down 29% to $47.17 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 adjusted EPS below estimates.
Ohmyhome Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) was down, falling 38% to $1.40 after the company priced its upsized $4.8 million public offering of 3,555,555 ordinary shares at $1.35 per share.
Also Check This Out:<a href="https://www.benzinga.com/trading-ideas/long-ideas/24/02/37120560/retractable-technologies-and-2-other-stocks-under-5-insiders-are-buying"> Retractable Technologies And 2 Other Stocks Under $5 Insiders Are Buying</a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 1.2% to $76.95 while gold traded down 0.2% at $2,004.20.
Silver traded up 1.2% to $22.425 on Wednesday while copper fell 0.3% to $3.6985.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mostly higher today. The eurozone&rsquo;s STOXX 600 gained 0.50%, London&rsquo;s FTSE 100 rose 0.75% while Spain&rsquo;s IBEX 35 Index fell 0.09% The German DAX rose 0.38% French CAC 40 rose 0.68% while Italy&rsquo;s FTSE MIB Index rose 0.63%.
The Eurozone economy stagnated in the final quarter of 2023, compared to a 0.1% decline in the prior three-month period. Industrial production in the Eurozone increased by 2.6% month-over-month in December.
The UK&rsquo;s inflation rate came in unchanged at 4.0% in January, compared to market estimates of 4.2%. Factory gate prices of goods produced by UK manufacturers fell 0.6% year-over-year in January following a 0.1% increase in December.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mixed on Wednesday, with Japan&rsquo;s Nikkei 225 falling 0.69%, Hong Kong&rsquo;s Hang Seng Index gaining 0.84% and India&rsquo;s S&amp;P BSE Sensex gaining around 0.5%.
India&rsquo;s wholesale prices increased by 0.27% year-over-year in January, compared to 0.73% in December.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. mortgage applications declined by 2.3% in the week ending Feb. 9, compared to a 3.7% increase in the prior week.
Crude oil inventories in the U.S. surged by 12.018 million barrels in the week ending Feb. 9, compared to market estimates of a 2.56 million rise.
Now Read This: <a href="https://www.benzinga.com/news/24/02/37120605/wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields"> Wall Street&#39;s Most Accurate Analysts&#39; Views On 3 Health Care Stocks Delivering High-Dividend Yields</a>

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

AZTR

ENGN

LYFT

QDEL

Dow Edges Higher; QuidelOrtho Shares Plummet

Shares of Sony Group Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sony#NYSE">SONY</a>) fell during Wednesday&rsquo;s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025.
Sony Group reported third-quarter FY23 sales growth of 22% year-on-year to $25.34 billion (&yen;3.75 trillion), beating the consensus of $24.62 billion. Adjusted EPS of $1.99 beat the consensus of $1.65.
Sony revised its FY23 sales outlook to $86.62 billion (&yen;12.4 trillion), down from a prior forecast of &yen;12.3 trillion versus the consensus of $87.32 billion.
Sony Group shares fell 6.3% to $89.86 on Wednesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Datasea Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtss#NASDAQ">DTSS</a>) shares jumped 1,173% to $18.59. On Tuesday, Datasea posted a narrower second-quarter loss.</li>
<li>Earlyworks Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elws#NASDAQ">ELWS</a>) surged 416% to $2.35 on two passive stakes.</li>
<li>enGene Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/engn#NASDAQ">ENGN</a>) jumped 95.5% to $14.90. The company&rsquo;s CEO Jason Hanson is resigning due to personal family and health reasons, though he will continue to support the company as a strategic advisor after a successor is appointed. Concurrently, enGene announced a private placement of 20 million common shares at $10.00 per share, representing a 31% premium over the previous day&rsquo;s closing price.</li>
<li>Cineverse Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnvs#NASDAQ">CNVS</a>) surged 92.9% to $2.9899. Cineverse announced forthcoming launch of AI-powered movie search platform cineSearch.</li>
<li>Cheche Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccg#NASDAQ">CCG</a>) gained 74.3% to $5.49.</li>
<li>MGO Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgol#NASDAQ">MGOL</a>) rose 66% to $0.6647.</li>
<li>Cogent Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cogt#NASDAQ">COGT</a>) surged 62.7% to $8.89.</li>
<li>Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iinn#NASDAQ">IINN</a>) gained 35% to $1.29 after the company announced it received the first ever U.S. Patent approval for an orbiting blood oxygenation delivery system, a core technology of the INSPIRA ART500 device.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) shares gained 34.3% to $16.29 after the company reported fourth-quarter sales of $1.22 billion and gross bookings of $3.7 billion, up 17% year-over-year. The company&rsquo;s CFO, Erin Brewer, said the adjusted EBITDA margin is projected to expand 50 basis points in 2024.</li>
<li>Healthcare Services Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) gained 25.7% to $11.90 following upbeat earnings.</li>
<li>Blink Charging Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blnk#NASDAQ">BLNK</a>) gained 24.2% to $3.3288. Blink Charging announced preliminary fourth-quarter revenue excess of $42 million.</li>
<li>Larimar Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lrmr#NASDAQ">LRMR</a>) rose 23.9% to $10.83. Larimar Therapeutics has priced the public offering of 17.16 million shares at $8.74 per share for gross proceeds of approximately $150 million.</li>
<li>Clene Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clnn#NASDAQ">CLNN</a>) gained 22.9% to $0.52.</li>
<li>Angi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/angi#NASDAQ">ANGI</a>) gained 22.2% to $2.97 following upbeat earnings.</li>
<li>Iris Energy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iren#NASDAQ">IREN</a>) shares rose 20.5% to $8.35.</li>
<li>CEVA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ceva#NASDAQ">CEVA</a>) gained 18.5% to $23.92 following upbeat earnings.</li>
<li>Great Lakes Dredge &amp; Dock Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gldd#NASDAQ">GLDD</a>) gained 17.1% to $9.47 following quarterly results.</li>
<li>Resideo Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rezi#NYSE">REZI</a>) rose 16.7% to $19.94 after the company reported better-than-expected quarterly financial results.</li>
<li>Kratos Defense &amp; Security Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktos#NASDAQ">KTOS</a>) jumped 15.7% to $20.59 following better-than-expected quarterly results.</li>
<li>Robinhood Markets, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) shares gained 14.7% to $13.58 after the company reported better-than-expected fourth-quarter financial results.</li>
<li>United Fire Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufcs#NASDAQ">UFCS</a>) rose 13.5% to $24.32 following upbeat results.</li>
<li>Allison Transmission Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alsn#NASDAQ">ALSN</a>) gained 13% to $69.53 after the company reported better-than-expected quarterly financial results.</li>
<li>MRC Global Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mrc#NYSE">MRC</a>) rose 12.1% to $11.64 following upbeat earnings.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) gained 11.5% to $156.50 amid strength in Bitcoin.</li>
<li>CCSC Technology International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cctg#NASDAQ">CCTG</a>) shares rose 10.2% to $3.56 after dipping around 10% on Tuesday.</li>
<li>Tower Semiconductor Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsem#NASDAQ">TSEM</a>) gained 8.5% to $31.07 following strong results.</li>
<li>Sentage Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sntg#NASDAQ">SNTG</a>) shares jumped 8.4% to $2.46.</li>
<li>Charles River Laboratories International, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crl#NYSE">CRL</a>) gained 7.2% to $236.00 after the company reported better-than-expected fourth-quarter results and issued guidance above estimates.</li>
<li>VBI Vaccines Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vbiv#NASDAQ">VBIV</a>) shares surged 5.2% to $0.6941. Brii Biosciences agreed to acquire VBI&#39;s IP rights in BRII-179 (VBI-2601) and plans to initiate technology transfer to expand clinical and commercial supplies.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Azitra, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aztr#NYSE">AZTR</a>) shares fell 69.5% to $0.2653. Azitra priced its $5 million public offering of 16.667 million common shares at $0.30 per share.</li>
<li>Ohmyhome Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) fell 40.7% to $1.3397 after the company priced its upsized $4.8 million public offering of 3,555,555 ordinary shares at $1.35 per share.</li>
<li>QuidelOrtho Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qdel#NASDAQ">QDEL</a>) fell 34.9% to $43.49 after the company reported worse-than-expected fourth-quarter financial results and issued FY24 adjusted EPS below estimates.</li>
<li>BioNexus Gene Lab Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bglc#NASDAQ">BGLC</a>) shares fell 34.4% to $1.03 after jumping 282% on Tuesday.</li>
<li>Sunworks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sunw#NASDAQ">SUNW</a>) fell 34.3% to $0.0662.</li>
<li>Enviva Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eva#NYSE">EVA</a>) fell 33.2% to $0.2977. Enviva is preparing to file for bankruptcy within days, the Wall Street Journal reported.</li>
<li>EpicQuest Education Group International Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eeiq#NASDAQ">EEIQ</a>) fell 27.5% to $1.16.</li>
<li>Nukkleus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nukk#NASDAQ">NUKK</a>) shares declined 21.6% to $1.5338 after surging over 55% on Tuesday. Goldman Sachs reported a 7.2% passive stake in Nukkleus as of Dec. 29, 2023.</li>
<li>Upstart Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upst#NASDAQ">UPST</a>) fell 20.5% to $26.19 after the company issued first-quarter revenue guidance below estimates.</li>
<li>Esports Entertainment Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gmbl#NASDAQ">GMBL</a>) shares fell 20% to $1.48. Esports Entertainment Group announced voluntary delisting from the Nasdaq and transfer to the OTCQB Venture Market.</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrteb#NASDAQ">QRTEB</a>) declined 18.4% to $4.69.</li>
<li>CAE Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cae#NYSE">CAE</a>) fell 12.2% to $18.36 after the company reported worse-than-expected quarterly financial results.</li>
<li>The Chemours Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cc#NYSE">CC</a>) dipped 10.5% to $27.29.</li>
<li>Vroom, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vrm#NASDAQ">VRM</a>) fell 10.5% to $13.71.</li>
<li>Maplebear Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cart#NASDAQ">CART</a>) fell 7.8% to $25.67 following quarterly results.</li>
<li>MGM Resorts International (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mgm#NYSE">MGM</a>) shares declined 7.4% to $42.29 after the company reported fourth-quarter financial results.</li>
<li>Akamai Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akam#NASDAQ">AKAM</a>) fell 7.3% to $115.89 after the company reported mixed quarterly financial results.</li>
<li>The Kraft Heinz Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/khc#NASDAQ">KHC</a>) declined 5.5% to $34.13 after the company reported mixed quarterly financial results.</li>
<li>Airbnb, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/abnb#NASDAQ">ABNB</a>) shares declined 5% to $143.25 after the company reported fourth-quarter financial results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/02/37126344/bitcoin-surpasses-51-000-stacks-emerges-as-top-gainer"> Bitcoin Surpasses $51,000; Stacks Emerges As Top Gainer</a>

Movers

ABNB

AKAM

ALSN

ANGI

BGLC

BLNK

CART

CCTG

CEVA

CLNN

CNVS

COGT

COIN

DTSS

EEIQ

ELWS

GLDD

GMBL

HOOD

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

IREN

KTOS

Larimar Therapeutics, Inc. - Common Stock

LRMR

MGOL

NUKK

QRTEB

REZI

SNTG

Sony Group Corporation American Depositary Shares

SONY

SUNW

TSEM

UFCS

UPST

VBIV

Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Healthcare Services Group names Vikas Singh as CFO

Healthcare Services ( ($HCSG) ) has shared an announcement. Healthcare Services Group, Inc. has appointed Vikas Singh as the new Executive Vice Pre...

Healthcare Services Announces Key Executive Appointments

Warning: HCSG is at high risk of performing badly

Healthcare Services discloses cybersecurity incident

Healthcare Services Q3 2024 Earnings Preview

Healthcare Services GAAP EPS of $0.19 misses by $0.01, revenue of $428.1M misses by $1.56M

Reports Q3 revenue $428.15M, consensus $429.66M. Ted Wahl, CEO, stated, "We're very pleased with our third quarter results, which underscore the po...

Healthcare Services reports Q3 EPS 19c, consensus 19c

Healthcare Services Group, Inc. (HCSG) Q3 2024 Earnings Call Transcript

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Healthcare Services (HCSG – Research Report), Thermo...

Analysts Are Bullish on Top Healthcare Stocks: Healthcare Services (HCSG), Thermo Fisher (TMO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Healthcare Services (HCSG – Research Report), Alig...

Comments

Healthcare Services Group

Notizie

Ultime notizie per Healthcare Services Group (NASDAQ:HCSG) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO